Beatriz Mantiñán-Gil

Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice.

Mónica Gayoso-Rey, C. Martínez-Reglero, M. Bravo-Amaro, 2021, Clinical therapeutics.

GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain.

E. Fernández-Rodríguez, R. Villar-Taibo, P. Álvarez-Castro, 2022, Endocrinologia, diabetes y nutricion.